Supplementary Figure S9 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

openalex

引用 0|浏览0
暂无评分
摘要
Changes in PSA levels between baseline and 4 weeks on-treatment in the different ctDNA kinetics groups
更多
查看译文
关键词
Metastatic Prostate Cancer,Prostate Cancer,Metabolic Reprogramming,Cancer,Tumor Evolution
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要